Streptogramins

DBCAT001412Pharmacologic classJ01FG

A class of natural cyclic peptide antibiotics produced by certain subspecies of STREPTOMYCES. They include two structurally unrelated components, STREPTOGRAMIN GROUP A and STREPTOGRAMIN GROUP B, which generally act synergistically to inhibit bacterial growth. A DrugBank category of 8 drugs. 2 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J01 — ANTIBACTERIALS FOR SYSTEMIC USE
J01F — MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01FG — Streptogramins
Also known as: Streptogramin
Drugs: Dalfopristin
Pristinamycin
Quinupristin
Viquidacin
Virginiamycin
Virginiamycin M1
Virginiamycin S1
Volpristin

What you can answer from here — as of August 24, 2016

8DrugsEach linked to its full drug card

Listed above

8Drug targetsEvery drug–target pair in the class, with bond type

4Marketed productsAcross the regions we cover, with dosage forms and routes

2Routes of administrationHow the drugs in this class are given

Which targets do Streptogramins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account